We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$237B
AUM Growth
+$24.6B
Cap. Flow
-$17.5B
Cap. Flow %
-7.37%
Top 10 Hldgs %
15.61%
Holding
8,813
New
706
Increased
2,953
Reduced
4,001
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Healthcare 6.25%
3 Consumer Discretionary 6.24%
4 Financials 5.99%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STND
6001
DELISTED
Standard AVB Financial Corp. Common Stock
STND
$43K ﹤0.01%
1,833
+1,236
+207% +$28.8K
PPSC
6002
DELISTED
PortfolioPlus S&P Small Cap ETF
PPSC
$43K ﹤0.01%
1,509
+623
+70% +$16K
BDRX
6003
Biodexa Pharmaceuticals
BDRX
$1.58M
0
FTAG icon
6004
First Trust Exchange-Traded Fund II First Trust Indxx Global Agriculture ETF
FTAG
$14.5M
$42K ﹤0.01%
2,164
-248
-10% -$4.52K
ISRA icon
6005
VanEck Israel ETF
ISRA
$159M
$42K ﹤0.01%
1,283
PROF
6006
Profound Medical
PROF
$269M
$42K ﹤0.01%
2,470
-1,075
-30% -$13.6K
SOHU
6007
Sohu.com
SOHU
$357M
$42K ﹤0.01%
4,622
-11,125
-71% -$86.8K
STRO icon
6008
Sutro Biopharma
STRO
$421M
$42K ﹤0.01%
538
-125
-19% -$12K
VRA icon
6009
Vera Bradley
VRA
$98.7M
$42K ﹤0.01%
9,456
-4,955
-34% -$24.7K
XERS icon
6010
Xeris Biopharma Holdings
XERS
$1.45B
$42K ﹤0.01%
15,922
-13,922
-47% -$48.5K
XXII
6011
22nd Century Group
XXII
$1.48M
0
HAYN
6012
DELISTED
Haynes International, Inc.
HAYN
$42K ﹤0.01%
1,818
-4,321
-70% -$96.1K
GRTS
6013
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$42K ﹤0.01%
6,353
-3,378
-35% -$22.7K
OPGN
6014
DELISTED
OpGen, Inc
OPGN
$42K ﹤0.01%
103
+51
+98% +$21.8K
EXPR
6015
DELISTED
Express, Inc.
EXPR
$42K ﹤0.01%
1,368
-918
-40% -$33.9K
SRT
6016
DELISTED
Startek Inc.
SRT
$42K ﹤0.01%
8,231
-2,755
-25% -$10.9K
GSV
6017
DELISTED
Gold Standard Ventures Corp.
GSV
$42K ﹤0.01%
50,794
-23,779
-32% -$15.7K
SLCT
6018
DELISTED
Select Bancorp, Inc.
SLCT
$42K ﹤0.01%
5,117
-4,986
-49% -$37.6K
ASLE icon
6019
AerSale
ASLE
$279M
$41K ﹤0.01%
3,958
+733
+23% +$7.46K
CCIF
6020
Carlyle Credit Income Fund
CCIF
$60.2M
$41K ﹤0.01%
+4,219
New +$39.5K
CMCT
6021
Creative Media & Community Trust
CMCT
$13M
0
DAX icon
6022
Global X DAX Germany ETF
DAX
$236M
$41K ﹤0.01%
1,577
+710
+82% +$16.7K
DHY
6023
Credit Suisse High Yield Credit Fund
DHY
$240M
$41K ﹤0.01%
20,560
+11,678
+131% +$22.2K
FSFG
6024
DELISTED
First Savings Financial Group
FSFG
$41K ﹤0.01%
2,832
+2,766
+4,191% +$39.5K
HBT icon
6025
HBT Financial
HBT
$1.32B
$41K ﹤0.01%
3,061
-2,244
-42% -$26.9K

Similar funds

UBS Group's Q2 2020 Portfolio in Review

As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.

  • UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
  • UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
  • UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
  • UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
  • UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
  • UBS Group opened 706 new positions and closed 776 in Q2 2020.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.